Contact details - International Organic Company

Operations Headquarters / HQ

International Organic Company (IOC Sp. z o. o.)

20 Poland Street
81-339 Gdynia, POLAND

Registration and Tax Data

NIP / VAT EU: PL 9571026227
KRS: 0000336317
REGON: 220864285
DUNS: 426683105

Entity verification: A company registered in the National Court Register, operating in accordance with Polish and European commercial law.

VIP Fast-Track: Priority Technology Transfer

This dedicated communication channel is reserved only for mature corporate projects, pharmacy chains and global brands transferring existing large-scale production to a medical hub IOC.

The iron criterion for entry is to have a ready technological specification (Master Batch Record / BOM) and a planned volume of a one-time batch exceeding 1,000,000 pieces.

Your Privilege: You bypass the standard implementation queue and start-up audit fees (Zero R&D Fee).
Fast Track: Your specification goes directly to the Chief Technologist, and the Senior Key Account Manager immediately optimizes the Target Price in accordance with ISO 22000.

⚠️ IMPORTANT - SYSTEM VERIFICATION:
Due to the automation of the Transfer Department processes, inquiries with volumes below 1 million pieces or projects requiring the development of a composition from scratch, sent via this form, are automatically rejected by the system without analysis and valuationIf your project involves a smaller starting scale, please select the dedicated tab. "Start-up / New Projects".

PRIORITY PATH: Transfer of Mass Production (> 1 million units)

Company name (Client) *

Name and surname of the decision-maker *

Work email address *

Direct telephone number (for quick contact) *

Planned batch size for one-time production (minimum 1,000,000 capsules) *

OPTION A: Attach Specifications (Shortcut)

If you have a ready-made Master Batch Record, specifications, Target Price Guidelines, or NDA, please attach the file and skip the questions below. We appreciate your time.

📎 Attach file (PDF, DOCX, XLSX, ZIP - max 20MB)

OPTION B: Enter details manually (Optional)

Complete only if you have not attached specifications in the box above.

Preferred Completion Date

Product type

Packing method

Number of sachets/capsules in a single package

Product Composition or Target Price

Additional remarks

I consent to the processing of my personal data for the purpose of initiating the priority service procedure (Fast-Track).

Medical Innovation R&D Department (Evidence-Based Medicine)

This project track is reserved only for doctors, clinics, investment funds and creators of elite premium brands whose absolute priority is scientific reliability and proven clinical effectiveness.

W IOC We don't produce generic substitutes from mass catalogs. We act as your private research institute. We design proprietary, uncompromising matrices based on patented raw materials, and each dose is verified against the global scientific literature (DOI numbers required).

Medical Dossier: We create a complete Project Science Book for you, which provides a strong legal, medical, and marketing shield for your brand.
Intellectual Property (IP): The innovation we build becomes your asset. We provide the option of a full IP Buy-Out to your company's balance sheet.

📌 PROJECT QUALIFICATION:
Inquiries from this section go directly to the desks of our Research Team. If your primary business goal is to create a budget-friendly product and compete with the lowest price on e-commerce platforms (private label models), please select the tab. "Start-up / New Projects".

Name of Clinic / Institution / Premium Brand *

Name and surname (Decision-maker / Academic title) *

Professional email address *

Direct contact telephone number *

Medical Brief

Primary Therapeutic Area/Product Target *

Preferred form of administration

Expected patented raw materials, guidelines or mechanism of action (Optional)

📎 Attach clinical literature, your own research, brief or NDA (PDF, DOCX, XLSX - max 20MB)

I consent to the processing of my personal data for the purpose of conducting the initial scientific verification of my project by the R&D Department IOC.

Implementation Department: New Projects and Brand Scaling

This project path was developed for investors, technology start-ups and developing brands that want to build their own portfolio based on rigorous quality standards (ISO 22000, ISO 27001) without yet having a ready-made large-scale specification (Master Batch Record).

As a certified hub medical (CDMO), we base our architecture on large-scale industry standards. We treat each project as an individual innovation. This means that we do not execute orders in a commoditized, low-cost model (so-called Private Label), based on optimization quality base components.

Financial Architecture and Engineering Requirements:

Research Process (Paid Discovery): Developing a proprietary product matrix from scratch and fully validating it to meet GIS/EFSA requirements is an independent engineering service for us. It requires a start-up budget allocation (CAPEX) of PLN 15,000 to PLN 35,000 net. This cost, within Technological Implementation Credit, is subject to full capitalization (deduction) when you order target mass production on our lines.
Supply Chain Security: Contracting the freshest, global raw materials while maintaining pharmaceutical rigor, we use a transparent tranche settlement model (50% / 25% / 25%), guaranteeing uncompromising quality each batch produced.

Operational recommendation of the Management Board: While respecting the capital and time of young business organizations, we understand that the early stages of startup projects may require drastic minimization of initial costs. If your current market strategy relies on competing on final price on e-commerce platforms, our regulatory standards may pose a disproportionate barrier to entry. In such cases, we respectfully recommend partnering with flexible contract bottlers who specialize in cost-optimization for smaller volumes.

Full name of the company or brand being created *

Name and surname of the decision-maker *

Contact email address *

Direct mobile number *

Financial and Project Qualification

Planned start-up budget (CAPEX) for R&D audit and technology alone *

Expected volume of the first production batch (number of capsules/packages) *

Preferred product form *

What problem is the product supposed to solve? / What are the main assumptions of the composition? *

MANDATORY DECLARATION:

I understood the strict rules of cooperation with the hub IOCI accept that the creation of new technology (Intellectual Property IP), legalization of composition and implementation of ISO 22000 on machines requires the payment of a non-refundable R&D audit in advance (from PLN 15,000 to PLN 35,000 net) before receiving a quote for mass production.

I consent to the processing of my personal data for the purpose of registering my inquiry in the qualification system. IOC.

Corporate Headquarters IOC CDMO
This form is intended solely for administrative matters, B2B offers from suppliers, media relations, and recruitment.
⚠️ For Supplement Manufacturing (CDMO) orders, please select one of the dedicated Implementation Tracks on the website. Production inquiries submitted here will not be processed.

Purpose of contact / Department *

Name of Company / Organization / Editorial Office *
(For job applications, enter "Candidate")

Name and Surname / Representative *

Work email address *

Contact telephone number (Required for B2B relations) *

⚠️ Authorization Procedure: Due to information protection standards (ISO 27001), key supply offers and business inquiries can be authorized by phone by our team.

Message Content / Case *

Attachment (CV, B2B Offer, Documentation) - Max 10MB

Corporate Statement: I consent to the processing of my personal data for the purpose of handling my inquiry by the administration. IOCI confirm that my message is not an inquiry about the production of supplements.